Fidelity Health Care Sector benefits from its exceptional leadership, strong supporting team of sector specialists, and thoughtful investment approach.
Fidelity Advisor Health Care Fund - Class M FACTX
- NAV / 1-Day Return 49.33 / +0.12 %
- Total Assets 2.9B
-
Adj. Expense Ratio
1.180%
- Expense Ratio 1.180%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 52%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 5:30 AM GMT+0
Morningstar’s Analysis FACTX
Will FACTX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the FACTX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of FACTX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 6.93 | 200M | Healthcare |
Danaher Corp | 6.79 | 196M | Healthcare |
Johnson & Johnson | 5.67 | 164M | Healthcare |
Thermo Fisher Scientific Inc | 3.62 | 104M | Healthcare |
UnitedHealth Group Inc | 3.02 | 87M | Healthcare |
Boston Scientific Corp | 2.79 | 81M | Healthcare |
Ascendis Pharma AS | 2.70 | 78M | Healthcare |
Alnylam Pharmaceuticals Inc | 2.44 | 71M | Healthcare |
Gilead Sciences Inc | 2.27 | 65M | Healthcare |
AbbVie Inc | 2.23 | 64M | Healthcare |
United States